Dr Sulaiman Al Habib Medical Group (4013)

Saudi Arabia
222.40
-4.20(-1.85%)
  • Volume:
    483,638
  • Bid/Ask:
    221.60/222.40
  • Day's Range:
    221.20 - 230.00

4013 Overview

Prev. Close
226.6
Day's Range
221.2-230
Revenue
7.55B
Open
229
52 wk Range
148-230
EPS
4.14
Volume
483,638
Market Cap
77.84B
Dividend (Yield)
3.32
(1.49%)
Average Vol. (3m)
266,362
P/E Ratio
54.77
Beta
-
1-Year Change
39%
Shares Outstanding
350,000,000
Next Earnings Date
May 27, 2022
What is your sentiment on Dr Sulaiman?
or
Market is currently closed. Voting is open during market hours.

Dr Sulaiman Al Habib Medical Group News

Dr Sulaiman Al Habib Medical Group Company Profile

Dr Sulaiman Al Habib Medical Group Company Profile

Dr. Sulaiman Al Habib Medical Services Group Company develops, owns, and operates hospitals and medical centers. The company operates spinal surgery, vascular, general medicine, urology, dental, diabetes and endocrine, ENT, family medicine, gastroenterology, general surgery, sport medicine, rheumatology, internal medicine, nutrition, nephrology, neurology, neurosurgery, orthopedic, OB/GYN, pulmonary, psychiatry, pediatric, and pain treatment clinics. It also operates physiotherapy, plastic surgery, cardiology, dermatology, in vitro fertilization, obesity treatment, ophthalmology, and laser hair removal centers; endoscopy, speech therapy, intensive care, hematology, kidney dialysis, sleep disorder treatment, laser and Lasik eye surgery, nuclear medicine, low vision, and ER units; a tissue laboratory and radiology center; and pharmacies. Dr. Sulaiman Al Habib Medical Services Group Company was founded in 1995 and is based in Riyadh, Saudi Arabia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellNeutralBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellSellStrong BuyStrong Buy
  • Dr. Sulaiman Al Habib Medical Services Group's board of directors recommended, in a meeting held on Oct. 23, the distribution of a 7% cash dividend, or SAR 0.7 per share, for the third quarter of 2021, according to a bourse filing.
    0
    • is this bullish
      0
      • Yes
        0
      • target 180
        0